AREV Life Sciences Global Corp.

    AREV Life Sciences Global Corp.

    CCSE:AREV
    0.09
    CAD
    -0.01
    (-10.00%)
    AREV Life Sciences Global Corp.
    CSE:AREV
    (Canadian Securities Exchange)

    Recent

    price

    0.09

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    TTM
    CAD
    50.83
    - -
    6.69
    16.36
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.02
    0.01
    0.01
    - -
    - -
    Revenue per Share
    -37.97
    -38.28
    -2.8
    9.75
    -7.57
    -6.23
    -13.07
    -16.45
    -24.4
    -0.42
    -1.44
    -0.36
    -0.07
    -0.05
    -0.05
    -0.01
    Basic EPS, GAAP
    -45.66
    -12.86
    -3.68
    1.55
    2.31
    -5.25
    -0.72
    -10.12
    -11.23
    -0.23
    -0.2
    -0.04
    -0.03
    -0.08
    -0.01
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    0.03
    - -
    - -
    0.01
    - -
    - -
    -0.01
    -0.02
    0.02
    0.11
    -0.01
    -0.06
    -0.03
    - -
    -0.03
    -0.04
    Book Value per Share
    0.02
    - -
    - -
    0.01
    - -
    - -
    -0.01
    -0.02
    - -
    0.11
    -0.01
    -0.06
    -0.03
    - -
    -0.03
    -0.04
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    2
    6
    9
    15
    20
    30
    32
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    -76.71
    - -
    -112.27
    59.84
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -1,554.39
    -342.72
    -653.59
    -2,839.86
    -2,919.02
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -1
    -8
    -3
    -1
    -1
    -1
    - -
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    -74.69
    - -
    -41.8
    59.6
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -1,639.99
    -550.37
    -388.36
    -2,940.37
    -3,322.8
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -1
    -1
    - -
    -1
    -1
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    -1
    -1
    - -
    -1
    -1
    Total Equity
    - -
    - -
    - -
    129.59
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    132.96
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    296.71
    Return on Capital (%)
    - -
    -188.8
    - -
    - -
    -91.44
    - -
    - -
    - -
    - -
    -178.47
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    32
    32
    32
    Market Capitalization
    6
    4
    3

    Working Capital

    CAD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    1
    1
    1
    Payables & Accruals
    1
    1
    1
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    316.75%
    290.45%
    918.75%
    Free Cash Flow
    152.6%
    49.48%
    -76.15%
    Net Income, GAAP
    122.9%
    124.43%
    45.82%
    Sales/Revenue/Turnover
    - -
    - -
    -80.74%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    -0.03
    -0.03
    -0.01
    - -
    -0.05
    2022
    -0.02
    -0.03
    -0.01
    - -
    -0.05
    2023
    -0.01
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business